Home › B-Cell Leukemia › Illinois › Chicago
B-Cell Leukemia clinical trials in Chicago, IL
3 studies for B-Cell Leukemia are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
RecruitingPhase 3
- Research Site, Chicago
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RecruitingPhase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RecruitingPhase 1/2
- University of Illinois at Chicago Cancer Center, Chicago
B-Cell Leukemia trials in other cities
- Houston, TX7 studies
- Washington, DC5 studies
- Dallas, TX5 studies
- Columbus, OH4 studies
- Portland, OR4 studies
- Philadelphia, PA3 studies
- Spokane, WA3 studies
- New York City, NY3 studies
- Boston, MA3 studies
- Clifton, NJ3 studies
- San Diego, CA3 studies
- Charlotte, NC3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.